USA - engelsk - NLM (National Library of Medicine)

burn solution foundations - tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - tetracaine (1.0%).......................pain & itch relief • for temporary relief of minor aches and pains of muscles and joints commonly assoicated with backache, arthritis, strains, bruises, sprains, and burns. • for cooling, deep-penetrating pain relief, apply a thin layer sparingly to affected areas. • apply up to 3 times daily.

USA - engelsk - NLM (National Library of Medicine)

galderma laboratories, l.p. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - pliaglis cream is a combination of lidocaine, an amide local anesthetic, and tetracaine, an ester local anesthetic, and is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis cream is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4)]. - pliaglis cream is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. pregnancy category b. no adequate and well-controlled studies have been conducted in pregnant women. pliaglis cream should be used during pregnancy only if the potential benefit justifies risk to the fetus. lidocaine was not teratogenic in rats at doses up to 60 mg/kg (8-fold higher than the level of lidocaine contained

USA - engelsk - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - lidocaine 70 mg in 1 g - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

USA - engelsk - NLM (National Library of Medicine)

oba pharmaceuticals, inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

USA - engelsk - NLM (National Library of Medicine)

oba pharmaceuticals, inc. - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987), tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv) - pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing, and laser-assisted tattoo removal. - pliaglis is contraindicated in patients with a known history of sensitivity to lidocaine or tetracaine, local anesthetics of the amide or ester type, or to any other component of the product [see warnings and precautions (5.4) ]. - pliaglis is contraindicated in patients with para-aminobenzoic acid (paba) hypersensitivity. risk summary there are no available data on pliaglis use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. available data from an epidemiologic study and case series with parenteral lidocaine use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage or other adverse maternal or fetal outcomes. published data on tetracain

Irland - engelsk - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - tetracaine hydrochloride - eye drops solution - 0.5 %w/v - tetracaine

Irland - engelsk - HPRA (Health Products Regulatory Authority)

bausch & lomb uk limited - tetracaine hydrochloride - eye drops solution - 1.0 %w/v - tetracaine

USA - engelsk - NLM (National Library of Medicine)

sincerus florida, llc - tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv), benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) -

USA - engelsk - NLM (National Library of Medicine)

sincerus florida, llc - tetracaine (unii: 0619f35cgv) (tetracaine - unii:0619f35cgv), lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) -

USA - engelsk - NLM (National Library of Medicine)

sambria pharmaceuticals, inc. - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride 20 mg in 1000 mg - external analgesic for temporary relief of pain and itching due to minor skin irritation ​do not use ​ in large quantities, particularly over raw surfaces or blistered areas ​stop use and ask a doctor if ​ • condition worsens, or if symptoms persist for more then 7 days or clear up and occur again within a few days.  discontinue use.